Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Clinical trial NCT03645928 · TERMINATED

Trial details

NCT number: NCT03645928
Sponsor: Iovance Biotherapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Squamous Cell Carcinoma of the Head and Neck Non-small Cell Lung Cancer

Start date: 2019-05-07
Primary completion: 2026-02-20
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.